Page 17 of articles about vaccine
Merck Animal Health announces European Union approval for PORCILIS M Hyo ID ONCE swine vaccine
Effect of porcine circovirus type 2 vaccine on postweaning performance and carcass composition
FMD situation in Paraguay
Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunization
Inovio Pharmaceuticals enters collaboration with U.S. Dept. of Homeland Security to assess foot & mouth disease synthetic vaccines' potential to help ensure Nation's food supply safety
Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains
RespiSure-ONE® now registered for use in day old piglets
Pfizer Animal Health launches FosteraTM PCV a new porcine circovirus vaccine
Transmission patterns of influenza virus in vaccinated and non-vaccinated pig populations
Merck Animal Health expands vaccine manufacturing unit at Elkhorn Biotechnology Excellence Center
Circovirus vaccination in pigs with subclinical porcine circovirus type 2 infection complicated by ileitis
SDSU, Boehringer Ingelheim team up against enterotoxic E. coli
Eradication of FMD in the Philippines (II)
In 1996, the NFMDTF drafted a national plan to address the 1995 FMD epidemic wherein 98,000 animals were reported to have been affected.
Merck Animal Health breaks ground for $18 million vaccine plant expansion
Eradication of FMD in the Philippines (I)
The FMD Eradication Project in the Philippines has formally ended but activities have been sustained even after obtaining FMD-freedom in Luzon having no clinical cases for 5 years with the last outbreak recorded in December 28, 2005.